LXR activation by GW3965 alters fat tissue distribution and adipose tissue infl ammation in ob/ob female mice

Journal of Lipid Research

Volumn 54, Issue 5, 2013, Pages 1300-1311

  Archer, Amena ^a   Stolarczyk, Émilie ^b   Doria, Maria Luisa ^c   Helguero, Luisa ^c   Domingues, Rosário ^c   Howard, Jane K ^b   Mode, Agneta ^a   Korach André, Marion ^a   Gustafsson, Jan Ake ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF AVEIRO   (Portugal)

^d University of Houston   (United States)

Author keywords

Immune cell infiltration; Lipidomic analysis; Liver X receptor

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ADIPOSE TRIGLYCERIDE LIPASE; HORMONE SENSITIVE LIPASE; INSULIN; LIVER X RECEPTOR; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; CELL POPULATION; CONTROLLED STUDY; FAT CONTENT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HOMEOSTASIS; INFLAMMATION; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID COMPOSITION; LIPID METABOLISM; LIPID STORAGE; LIPIDOMICS; LIPOGENESIS; LIPOTOXICITY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; METABOLIC REGULATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SUBCUTANEOUS FAT; WHITE ADIPOSE TISSUE;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; BENZOATES; BENZYLAMINES; BODY FAT DISTRIBUTION; FEMALE; INFLAMMATION; LIPOLYSIS; MACROPHAGES; MICE; OBESITY; ORPHAN NUCLEAR RECEPTORS;

EID: 84876815165     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M033977     Document Type: Article

References (56)

1. Mokdad, A. H., B. A. Bowman, E. S. Ford, F. Vinicor, J. S. Marks, and J. P. Koplan. 2001. The continuing epidemics of obesity and diabetes in the United States. JAMA. 286 : 1195-1200.
2. Whitlock, G., S. Lewington, P. Sherliker, R. Clarke, J. Emberson, J. Halsey, N. Qizilbash, R. Collins, and R. Peto. 2009. Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. Lancet. 373 : 1083-1096.
3. Lelliott, C., and A. J. Vidal-Puig. 2004. Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation. Int. J. Obes. Relat. Metab. Disord. 28 (Suppl. 4) : S22-S28.
4. Unger, R. H. 2003. Minireview: Weapons of lean body mass destruction: The role of ectopic lipids in the metabolic syndrome. Endocrinology. 144 : 5159-5165.
5. Bastard, J. P., M. Maachi, C. Lagathu, M. J. Kim, M. Caron, H. Vidal, J. Capeau, and B. Feve. 2006. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17 : 4-12.
6. Hotamisligil, G. S. 2006. Inflammation and metabolic disorders. Nature. 444 : 860-867.
7. Hellmann, J., Y. Tang, M. Kosuri, A. Bhatnagar, and M. Spite. 2011. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 25 : 2399-2407.
8. Kurokawa, J., H. Nagano, O. Ohara, N. Kubota, T. Kadowaki, S. Arai, and T. Miyazaki. 2011. Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue. Proc. Natl. Acad. Sci. USA. 108 : 12072-12077.
9. Lumeng, C. N., J. L. Bodzin, and A. R. Saltiel. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117 : 175-184.
10. Nishimura, S., I. Manabe, M. Nagasaki, K. Eto, H. Yamashita, M. Ohsugi, M. Otsu, K. Hara, K. Ueki, S. Sugiura, et al. 2009. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15 : 914-920.
11. O'Rourke, R. W., M. D. Metcalf, A. E. White, A. Madala, B. R. Winters, I. I. Maizlin, B. A. Jobe, C. T. Roberts, Jr., M. K. Slifka, and D. L. Marks. 2009. Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. Int. J. Obes. (Lond.) 33 : 978-990.
12. Meng, K., C. H. Lee, and F. Saremi. 2010. Metabolic syndrome and ectopic fat deposition: What can CT and MR provide? Acad. Radiol. 17 : 1302-1312.
13. Savage, D. B., K. F. Petersen, and G. I. Shulman. 2007. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87 : 507-520.
14. Virtue, S., and A. Vidal-Puig. 2010. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome-an allostatic perspective. Biochim. Biophys. Acta. 1801 : 338-349.
15. Hellmér, J., C. Marcus, T. Sonnenfeld, and P. Arner. 1992. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J. Clin. Endocrinol. Metab. 75 : 15-20.
16. Fujioka, S., Y. Matsuzawa, K. Tokunaga, T. Kawamoto, T. Kobatake, Y. Keno, K. Kotani, S. Yoshida, and S. Tarui. 1991. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int. J. Obes. 15 : 853-859.
17. Goodpaster, B. H., D. E. Kelley, R. R. Wing, A. Meier, and F. L. Thaete. 1999. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes. 48 : 839-847.
18. Bruun, J. M., A. S. Lihn, S. B. Pedersen, and B. Richelsen. 2005. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): Implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab. 90 : 2282-2289.
19. Cancello, R., J. Tordjman, C. Poitou, G. Guilhem, J. L. Bouillot, D. Hugol, C. Coussieu, A. Basdevant, A. Bar Hen, P. Bedossa, et al. 2006. Increased infi ltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes. 55 : 1554-1561.
20. Bensinger, S. J., M. N. Bradley, S. B. Joseph, N. Zelcer, E. M. Janssen, M. A. Hausner, R. Shih, J. S. Parks, P. A. Edwards, B. D. Jamieson, et al. 2008. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell. 134 : 97-111.
21. Zelcer, N., and P. Tontonoz. 2006. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116 : 607-614.
22. Laffitte, B. A., J. J. Repa, S. B. Joseph, D. C. Wilpitz, H. R. Kast, D. J. Mangelsdorf, and P. Tontonoz. 2001. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA. 98 : 507-512.
23. Janowski, B. A., P. J. Willy, T. R. Devi, J. R. Falck, and D. J. Mangelsdorf. 1996. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature. 383 : 728-731.
24. Repa, J. J., G. Liang, J. Ou, Y. Bashmakov, J. M. Lobaccaro, I. Shimomura, B. Shan, M. S. Brown, J. L. Goldstein, and D. J. Mangelsdorf. 2000. Regulation of mouse sterol regulatory elementbinding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14 : 2819-2830.
25. Laffitte, B. A., L. C. Chao, J. Li, R. Walczak, S. Hummasti, S. B. Joseph, A. Castrillo, D. C. Wilpitz, D. J. Mangelsdorf, J. L. Collins, et al. 2003. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc. Natl. Acad. Sci. USA. 100 : 5419-5424.
26. Castrillo, A., S. B. Joseph, C. Marathe, D. J. Mangelsdorf, and P. Tontonoz. 2003. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278 : 10443-10449.
27. Joseph, S. B., A. Castrillo, B. A. Laffitte, D. J. Mangelsdorf, and P. Tontonoz. 2003. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9 : 213-219.
28. Steffensen, K. R., M. Nilsson, G. U. Schuster, T. M. Stulnig, K. Dahlman-Wright, and J. A. Gustafsson. 2003. Gene expression profi ling in adipose tissue indicates different transcriptional mechanisms of liver X receptors alpha and beta, respectively. Biochem. Biophys. Res. Commun. 310 : 589-593.
29. Inouye, K. E., H. Shi, J. K. Howard, C. H. Daly, G. M. Lord, B. J. Rollins, and J. S. Flier. 2007. Absence of CC chemokine ligand 2 does not limit obesity-associated infi ltration of macrophages into adipose tissue. Diabetes. 56 : 2242-2250.
30. Korach-André, M., A. Archer, C. Gabbi, R. P. Barros, M. Pedrelli, K. R. Steffensen, A. T. Pettersson, J. Laurencikiene, P. Parini, and J. A. Gustafsson. 2011. Liver X receptors regulate de novo lipogenesis in a tissue-specific manner in C57BL/6 female mice. Am. J. Physiol. Endocrinol. Metab. 301 : E210-E222.
31. Ruiz, J., T. Antequera, A. I. Andres, M. J. Petron, and E. Muriel. 2004. Improvement of a solid phase extraction method for analysis of lipid fractions in muscle foods. Anal. Chim. Acta. 520 : 201-205.
32. Dória, M. L., Z. Cotrim, B. Macedo, C. Simoes, P. Domingues, L. Helguero, and M. R. Domingues. 2012. Lipidomic approach to identify patterns in phospholipid profiles and defi ne class differences in mammary epithelial and breast cancer cells. Breast Cancer Res. Treat. 133 : 635-648.
33. Dória, M. L., C. Z. Cotrim, C. Simoes, B. Macedo, P. Domingues, M. R. Domingues, and L. A. Helguero. 2013. Lipidomic analysis of phospholipids from human mammary epithelial and breast cancer cell lines. J. Cell. Physiol. 228 : 457-468.
34. Aued-Pimentel, S., J. H. Lago, M. H. Chaves, and E. E. Kumagai. 2004. Evaluation of a methylation procedure to determine cyclopropenoids fatty acids from Sterculia striata St. Hil. Et Nauds seed oil. J. Chromatogr. A. 1054 : 235-239.
35. Ishibashi, M., R. Filomenko, C. Rebe, A. Chevriaux, A. Varin, V. Derangere, G. Bessede, P. Gambert, L. Lagrost, and D. Masson. Knock-down of the oxysterol receptor LXRalpha impairs cholesterol efflux in human primary macrophages: Lack of compensation by LXRbeta activation. Biochem. Pharmacol. Epub ahead of print. January 9, 2013; doi:10.1016/j.bcp.2012.12.024.
36. Pietiläinen, K. H., T. Rog, T. Seppanen-Laakso, S. Virtue, P. Gopalacharyulu, J. Tang, S. Rodriguez-Cuenca, A. Maciejewski, J. Naukkarinen, A. L. Ruskeepaa, et al. 2011. Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol. 9 : E1000623.
37. Prieur, X., C. Y. Mok, V. R. Velagapudi, V. Nunez, L. Fuentes, D. Montaner, K. Ishikawa, A. Camacho, N. Barbarroja, S. O'Rahilly, et al. 2011. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes. 60 : 797-809.
38. Walcher, D., A. Kummel, B. Kehrle, H. Bach, M. Grub, R. Durst, V. Hombach, and N. Marx. 2006. LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes. Arterioscler. Thromb. Vasc. Biol. 26 : 1022-1028.
39. Walcher, D., D. Vasic, P. Heinz, H. Bach, R. Durst, A. Hausauer, V. Hombach, and N. Marx. 2010. LXR activation inhibits chemokineinduced CD4-positive lymphocyte migration. Basic Res. Cardiol. 105 : 487-494.
40. Calder, P. C. 2006. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83 : 1505S-1519S.
41. Hajer, G. R., T. W. van Haeften, and F. L. Visseren. 2008. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J. 29 : 2959-2971.
42. Olefsky, J. M., and C. K. Glass. 2010. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72 : 219-246.
43. Pascual-García, M., J. M. Carbo, T. Leon, J. Matalonga, R. Out, T. Van Berkel, M. R. Sarrias, F. Lozano, A. Celada, and A. F. Valledor. 2011. Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4. J. Immunol. 186 : 4656-4667.
44. Garaulet, M., J. J. Hernandez-Morante, J. Lujan, F. J. Tebar, and S. Zamora. 2006. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans. Int. J. Obes. (Lond.) 30 : 899-905.
45. Schoen, R. E., R. W. Evans, S. S. Sankey, J. L. Weissfeld, and L. Kuller. 1996. Does visceral adipose tissue differ from subcutaneous adipose tissue in fatty acid content? Int. J. Obes. Relat. Metab. Disord. 20 : 346-352.
46. Suganami, T., J. Nishida, and Y. Ogawa. 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 25 : 2062-2068.
47. Yeop Han, C., A. Y. Kargi, M. Omer, C. K. Chan, M. Wabitsch, K. D. O'Brien, T. N. Wight, and A. Chait. 2010. Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: Dissociation of adipocyte hypertrophy from inflammation. Diabetes. 59 : 386-396.
48. Suganami, T., K. Tanimoto-Koyama, J. Nishida, M. Itoh, X. Yuan, S. Mizuarai, H. Kotani, S. Yamaoka, K. Miyake, S. Aoe, et al. 2007. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 27 : 84-91.
49. Tsukumo, D. M., M. A. Carvalho-Filho, J. B. Carvalheira, P. O. Prada, S. M. Hirabara, A. A. Schenka, E. P. Araujo, J. Vassallo, R. Curi, L. A. Velloso, et al. 2007. Loss-of-function mutation in Tolllike receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes. 56 : 1986-1998.
50. Kumar, H., T. Kawai, and S. Akira. 2009. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388 : 621-625.
51. Erridge, C., and N. J. Samani. 2009. Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler. Thromb. Vasc. Biol. 29 : 1944-1949.
52. Lee, J. Y., A. Plakidas, W. H. Lee, A. Heikkinen, P. Chanmugam, G. Bray, and D. H. Hwang. 2003. Differential modulation of Toll-like receptors by fatty acids: Preferential inhibition by n-3 polyunsaturated fatty acids. J. Lipid Res. 44 : 479-486.
53. Lee, J. Y., K. H. Sohn, S. H. Rhee, and D. Hwang. 2001. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276 : 16683-16689.
54. Lee, J. Y., J. Ye, Z. Gao, H. S. Youn, W. H. Lee, L. Zhao, N. Sizemore, and D. H. Hwang. 2003. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 278 : 37041-37051.
55. Grefhorst, A., T. H. van Dijk, A. Hammer, F. H. van der Sluijs, R. Havinga, L. M. Havekes, J. A. Romijn, P. H. Groot, D. J. Reijngoud, and F. Kuipers. 2005. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am. J. Physiol. Endocrinol. Metab. 289 : E829-E838.
56. Medina-Gomez, G., S. L. Gray, L. Yetukuri, K. Shimomura, S. Virtue, M. Campbell, R. K. Curtis, M. Jimenez-Linan, M. Blount, G. S. Yeo, et al. 2007. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 3 : E64